
    
      There are many tocolytic agents may have a role in conservative management of placenta previa
      such as magnesium sulfate, calcium channel blockers and Î²-sympathormimetics. In 2004 Sharma
      suggests that ritodrine hydrochloride in patients with symptomatic placenta previa tends to
      prolong the pregnancy and result in an increase in birth weight of the babies without causing
      any adverse effect on the mother and fetus
    
  